Although we take the Government’s state of emergency seriously, in order not to pause our first cancer screening test N-NOSE completely, we continue the analysis in our analysis center and three R&D centers while taking necessary steps to prevent infection.
To support our employees to cope with the situation, we have decided to reward them with lump-sum payments (JPY 30,000 per employee).
We will continue to focus on our efforts to expand N-NOSE tests so that we can provide it for as many people as possible.
A paper on the latest technology for the early diagnosis and treatment of pancreatic cancer by the Joint research between Osaka University and H . . .2020.07.10
With our N-NOSE® nematode cancer test, inspectors have manually performed part of the inspection process until now. This time, we have succeeded . . .2020.07.03
A book "Prime Archives in Cancer Research" was published. This book includes our joint paper with Osaka University on pancreatic cancer "Applic . . .2020.06.18